garcinol has been researched along with Cancer of Head in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basha, J; Chatterjee, S; Chen, L; Kumar, AP; Kundu, TK; Li, F; Sethi, G; Shanmugam, MK | 1 |
Ahn, KS; Goh, BC; Hui, KM; Kumar, AP; Kundu, T; Li, F; Loo, SY; Mandal, S; Ong, TH; Sethi, G; Shanmugam, MK; Siveen, KS; Swamy, MM; Wang, F; Wang, LZ | 1 |
2 other study(ies) available for garcinol and Cancer of Head
Article | Year |
---|---|
Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Inflammation Mediators; Male; Mice; Mice, Nude; NF-kappa B; Plant Extracts; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT3 Transcription Factor; Terpenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2013 |
Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Cisplatin; Down-Regulation; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Mice; Mice, Nude; Plant Extracts; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Terpenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |